SCHEMBL24153512

SCHEMBL24153512

CCCCCCN1CC(=O)N2CCN(Cc3c(CC)sc4ccccc34)CC2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24153493 0.96 HDAC6 (0.38) —
SCHEMBL24153499 0.90 HTR1A (0.39) —
SCHEMBL24153472 0.89 HTR1A (0.39) —
SCHEMBL24153600 0.88 MCHR1 (0.37) —
SCHEMBL24153475 0.86 KMT2A (0.38) —
SCHEMBL24153484 0.86 NPY1R (0.37) —
SCHEMBL24153602 0.85 HSD17B10 (0.38) —
SCHEMBL24939891 0.84 LMNA (0.42) —
SCHEMBL24938892 0.84 NPY1R (0.41) —
SCHEMBL24153500 0.83 HTR1A (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019094-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME HOLOSMEDIC (KR) 2023-01-19 — — US disclosed
WO-2021261969-A1 PREPARATION METHOD FOR NOVEL COMPOUND 홀로스메딕 주식회사 2021-12-30 — — WO disclosed
Send feedback